Neximmune Stock Price on March 31, 2021

NEXI Stock  USD 3.30  0.15  4.76%   
If you're considering investing in Neximmune Stock, it is important to understand the factors that can impact its price. As of today, the current price of Neximmune stands at 3.30, as last reported on the 19th of April, with the highest price reaching 3.37 and the lowest price hitting 3.06 during the day. Neximmune has Sharpe Ratio of -0.0082, which conveys that the firm had a -0.0082% return per unit of risk over the last 3 months. Neximmune exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Neximmune's Standard Deviation of 13.97, mean deviation of 7.36, and Risk Adjusted Performance of (0.03) to check out the risk estimate we provide.
  
As of now, Neximmune's Common Stock Shares Outstanding is increasing as compared to previous years. The Neximmune's current Other Stockholder Equity is estimated to increase to about 237.4 M, while Total Stockholder Equity is projected to decrease to under 3.3 M. . As of now, Neximmune's Price Fair Value is decreasing as compared to previous years. Neximmune Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0082

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsNEXI

Estimated Market Risk

 13.84
  actual daily
96
96% of assets are less volatile

Expected Return

 -0.11
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.01
  actual daily
0
Most of other assets perform better
Based on monthly moving average Neximmune is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neximmune by adding Neximmune to a well-diversified portfolio.
Price Book
0.5697
Book Value
7.801
Enterprise Value
-4.7 M
Enterprise Value Ebitda
0.0855
Shares Float
753.2 K

Neximmune Valuation on March 31, 2021

It is possible to determine the worth of Neximmune on a given historical date. On March 31, 2021 Neximmune was worth 4.54 at the beginning of the trading date compared to the closed value of 117.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Neximmune stock. Still, in general, we apply an absolute valuation method to find Neximmune's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Neximmune where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Neximmune's related companies.
 Open High Low Close Volume
04/04/2022
  4.54    117.00    117.00    117.00    9,507  
  4.63    105.50    105.50    105.50    10,002  
Backtest Neximmune  |  Neximmune History  |  Neximmune Valuation Next  
Open Value
4.54
117.0
Closing Value
46.07
Upside

Neximmune Trading Date Momentum on March 31, 2021

The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.

Neximmune Fundamentals Correlations and Trends

By evaluating Neximmune's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Neximmune's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Neximmune financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Neximmune Stock history

Neximmune investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Neximmune is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Neximmune will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Neximmune stock prices may prove useful in developing a viable investing in Neximmune
Last ReportedProjected for Next Year
Common Stock Shares OutstandingB1.1 B
Net Loss-56.3 M-59.1 M

Neximmune Stock Technical Analysis

Neximmune technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Neximmune technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Neximmune trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Neximmune Period Price Range

Low
April 4, 2022
112.46  2,477%
High

 4.54 

     

 117.00 

Neximmune April 19, 2024 Market Strength

Market strength indicators help investors to evaluate how Neximmune stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Neximmune shares will generate the highest return on investment. By undertsting and applying Neximmune stock market strength indicators, traders can identify Neximmune entry and exit signals to maximize returns

Neximmune Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Neximmune's price direction in advance. Along with the technical and fundamental analysis of Neximmune Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Neximmune to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Neximmune offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Neximmune's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Neximmune Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Neximmune Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neximmune. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
For more detail on how to invest in Neximmune Stock please use our How to Invest in Neximmune guide.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Complementary Tools for Neximmune Stock analysis

When running Neximmune's price analysis, check to measure Neximmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neximmune is operating at the current time. Most of Neximmune's value examination focuses on studying past and present price action to predict the probability of Neximmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neximmune's price. Additionally, you may evaluate how the addition of Neximmune to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Transaction History
View history of all your transactions and understand their impact on performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Is Neximmune's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neximmune. If investors know Neximmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neximmune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(42.05)
Return On Assets
(0.78)
Return On Equity
(1.57)
The market value of Neximmune is measured differently than its book value, which is the value of Neximmune that is recorded on the company's balance sheet. Investors also form their own opinion of Neximmune's value that differs from its market value or its book value, called intrinsic value, which is Neximmune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neximmune's market value can be influenced by many factors that don't directly affect Neximmune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neximmune's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neximmune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neximmune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.